Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia

Thumbnail
View/ Open

Show full item record
Author
McCubrey, James A.
URI
http://hdl.handle.net/10342/9629
Subject
 NUP214-ABL1; PI3K/Akt/mTOR signaling; T-Acute Lymphoblastic Leukemia 
Date
2016-11-03
Citation:
APA:
McCubrey, James A.. (November 2016). Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia. , (), - . Retrieved from http://hdl.handle.net/10342/9629

Display/Hide MLA, Chicago and APA citation formats.

MLA:
McCubrey, James A.. "Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia". . . (), November 2016. July 11, 2024. http://hdl.handle.net/10342/9629.
Chicago:
McCubrey, James A., "Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia," , no. (November 2016), http://hdl.handle.net/10342/9629 (accessed July 11, 2024).
AMA:
McCubrey, James A.. Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia. . November 2016; (): . http://hdl.handle.net/10342/9629. Accessed July 11, 2024.
Collections